The Oral Solid Dosage Manufacturing market size is USD 608.9 Bn in 2026.
The Oral Solid Dosage Manufacturing market is projected to grow at a CAGR of 5% by 2033.
The Oral Solid Dosage Manufacturing market growth drivers include rising demand for generic drugs, growing aging population, and advancements in pharmaceutical formulations.
North America is a dominating region for Oral Solid Dosage Manufacturing market.
Pfizer Inc., Piramal Pharma Solutions, Alcami, Cambrex, and Catalent are some leading industry players in the Oral Solid Dosage Manufacturing market.